The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors

• Status: Terminated
• Trial end date: 2005-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine the effect of mifepristone on the expression of three cervical EP3 receptor isoforms (EP3-2, EP3-3 and EP3-6) in pregnant women ≤63 days gestational age.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Southern California
• Treatments: Mifepristone

Criteria

Inclusion Criteria:

• good general health

• ≥18 years old

• seeking termination of a viable intrauterine pregnancy of ≤63 days, without any evidence of a threatened or spontaneous abortion

Exclusion Criteria:

• medical problems

• confirmed or suspected ectopic pregnancy

• having taken medications in the seven days prior to enrollment that would affect PG synthesis or metabolism of mifepristone